Among outpatients with hyperkalemia , open-label sodium zirconium cyclosilicate reduced serum potassium to normal levels within @ hours ; compared with placebo , all @ doses of zirconium cyclosilicate resulted in lower potassium levels and a higher proportion of patients with normal potassium levels for up to @ days .